ClinConnect ClinConnect Logo
Search / Trial NCT00185198

Efficacy and Safety of Testogel® in Men With Partial Androgen Deficiency of Aging Males (PADAM)

Launched by BAYER · Sep 9, 2005

Trial Information

Current as of May 06, 2025

Completed

Keywords

Partial Androgen Deficiency Of Aging Males (Padam)

ClinConnect Summary

The study has previously been posted by Schering AG, Germany. Schering AG, Germany has been renamed to Bayer Schering Pharma AG, Germany.

Bayer Schering Pharma AG, Germany is the sponsor of the trial.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Symptomatic hypogonadism
  • Willing to avoid significant change in the pattern of physical exercise and lifestyle for the duration of the study
  • Exclusion Criteria:
  • Patients with any contraindication for testosterone use

About Bayer

Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.

Locations

Innsbruck, , Austria

Napoli, , Italy

Dublin, , Ireland

Wien, , Austria

Leipzig, Sachsen, Germany

Madrid, , Spain

Tampere, , Finland

Barcelona, , Spain

Graz, , Austria

Bonn, Nordrhein Westfalen, Germany

Roma, , Italy

Salzburg, , Austria

Helsinki, , Finland

Oulu, , Finland

Halle, Sachsen Anhalt, Germany

Dresden, Sachsen, Germany

Magdeburg, , Germany

Milano, , Italy

Hospitalet De Llobregat, Barcelona, Spain

Goteborg, , Sweden

Malmo, , Sweden

Stockholm, , Sweden

Reading, Berkshire, United Kingdom

Wigan, Manchester, United Kingdom

Cardiff, , United Kingdom

London, , United Kingdom

Sheffield, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Bayer Study Director

Study Director

Bayer

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials